NIH-funded research R21 grant

Understanding how a genetic variant affects immune response

Official title: New insight into innate immune regulation through mechanistic studies of a novel oligoadenylate synthetase-like (OASL) gain-of-function variant

Funded at Emory University · NIH-11101111 · Data updated 2026-11-12

This study is looking at a genetic change that affects a protein in your immune system, which might make you more prone to infections, and the goal is to learn more about how this works so we can find better treatments for people with immune problems.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startJune 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$195,625
NIH project number5R21AI175846-02
Project IDNIH-11101111 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with inborn errors of immunity, particularly those experiencing recurrent infections or autoimmune conditions.

Less likely to help

Patients without genetic immune deficiencies or those not affected by immune-related conditions may not benefit from this research.

What this research studies

This research investigates a specific genetic variant that impacts the innate immune system, particularly focusing on a protein called OASL. The study aims to understand how a mutation in this protein can lead to increased sensitivity to infections and other immune-related issues. By examining the molecular mechanisms involved, researchers hope to uncover new insights into how the immune system functions and how it can be regulated. This could ultimately lead to better treatments for patients with immune deficiencies.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with inherited immune disorders.

How similar studies have gone: Previous research has shown success in understanding immune deficiencies through genetic studies, making this approach promising.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Conn, Graeme L — Emory University
  • Study coordinator: Conn, Graeme L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.